Liu Chunwang – Trademark Portfolio

Entity Type: 01

Liu Chunwang owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CLAMPIT, SOLUMED, and QUIETZZZ. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 24 (Fabrics) and Class 8 (Hand Tools). Headquartered in Hebei Province.

Chaheji Township, Bazhou City,

No.3791, Liuzhuang Village,

Hebei Province 065799 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Liu Chunwang's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

23
Yarns & Threads (1 filing)

Yarns and threads, for textile use

Frequently Asked Questions

How many trademarks does Liu Chunwang have?

Liu Chunwang has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Liu Chunwang file in?

Liu Chunwang files trademarks across 4 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 8 (Hand Tools), Class 5 (Pharmaceuticals), Class 23 (Yarns & Threads). Class 24 covers textiles and textile goods; bed covers; table covers.

What are Liu Chunwang's most well-known trademarks?

Liu Chunwang's registered trademark portfolio includes well-known marks such as CLAMPIT, SOLUMED, and QUIETZZZ. These are among 3 currently registered trademarks in the portfolio.

What is Liu Chunwang's trademark registration success rate?

Liu Chunwang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.